1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

NEA Management Company, LLC Buys Oyster Point Pharma Inc, Black Diamond Therapeutics Inc, Imara Inc, Sells Ra Pharmaceuticals Inc, Epizyme Inc, Mersana Therapeutics Inc

Timonium, MD, based Investment company NEA Management Company, LLC (Current Portfolio) buys Oyster Point Pharma Inc, Black Diamond Therapeutics Inc, Imara Inc, Mirum Pharmaceuticals Inc, Casper Sleep Inc, sells Ra Pharmaceuticals Inc, Epizyme Inc, Mersana Therapeutics Inc, Senseonics Holdings Inc, Surface Oncology Inc during the 3-months ended 2020Q2, according to the most recent filings of the investment company, NEA Management Company, LLC. As of 2020Q2, NEA Management Company, LLC owns 45 stocks with a total value of $2.4 billion. These are the details of the buys and sells.

For the details of NEA Management Company, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/nea+management+company%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of NEA Management Company, LLC
  1. Sprout Social Inc (SPT) - 9,046,080 shares, 10.22% of the total portfolio.
  2. Mersana Therapeutics Inc (MRSN) - 7,959,520 shares, 7.79% of the total portfolio. Shares reduced by 33.47%
  3. Oyster Point Pharma Inc (OYST) - 5,925,287 shares, 7.16% of the total portfolio. New Position
  4. Adaptimmune Therapeutics PLC (ADAP) - 17,082,611 shares, 7.15% of the total portfolio.
  5. Allakos Inc (ALLK) - 2,268,188 shares, 6.82% of the total portfolio.
New Purchase: Oyster Point Pharma Inc (OYST)

NEA Management Company, LLC initiated holding in Oyster Point Pharma Inc. The purchase prices were between $27.86 and $35.93, with an estimated average price of $30.18. The stock is now traded at around $26.91. The impact to a portfolio due to this purchase was 7.16%. The holding were 5,925,287 shares as of .

New Purchase: Black Diamond Therapeutics Inc (BDTX)

NEA Management Company, LLC initiated holding in Black Diamond Therapeutics Inc. The purchase prices were between $22.3 and $44.8, with an estimated average price of $36.52. The stock is now traded at around $29.25. The impact to a portfolio due to this purchase was 6.08%. The holding were 3,449,845 shares as of .

New Purchase: Imara Inc (IMRA)

NEA Management Company, LLC initiated holding in Imara Inc. The purchase prices were between $15.6 and $54.87, with an estimated average price of $27.6. The stock is now traded at around $20.50. The impact to a portfolio due to this purchase was 4.64%. The holding were 4,017,170 shares as of .

New Purchase: Mirum Pharmaceuticals Inc (MIRM)

NEA Management Company, LLC initiated holding in Mirum Pharmaceuticals Inc. The purchase prices were between $11.51 and $20.97, with an estimated average price of $16.65. The stock is now traded at around $22.37. The impact to a portfolio due to this purchase was 3.41%. The holding were 4,187,801 shares as of .

New Purchase: Casper Sleep Inc (CSPR)

NEA Management Company, LLC initiated holding in Casper Sleep Inc. The purchase prices were between $3.95 and $9.67, with an estimated average price of $7.02. The stock is now traded at around $8.76. The impact to a portfolio due to this purchase was 2.34%. The holding were 6,226,040 shares as of .

New Purchase: Trevi Therapeutics Inc (TRVI)

NEA Management Company, LLC initiated holding in Trevi Therapeutics Inc. The purchase prices were between $2.51 and $6.87, with an estimated average price of $3.49. The stock is now traded at around $4.63. The impact to a portfolio due to this purchase was 1.64%. The holding were 5,940,796 shares as of .

Added: AVEO Pharmaceuticals Inc (VPA1)

NEA Management Company, LLC added to a holding in AVEO Pharmaceuticals Inc by 56.59%. The purchase prices were between $3.2 and $9.65, with an estimated average price of $5.63. The stock is now traded at around $3.58. The impact to a portfolio due to this purchase was 0.31%. The holding were 3,952,958 shares as of .

Sold Out: Ra Pharmaceuticals Inc (RARX)

NEA Management Company, LLC sold out a holding in Ra Pharmaceuticals Inc. The sale prices were between $48 and $48.01, with an estimated average price of $48.

Sold Out: Epizyme Inc (EPZM)

NEA Management Company, LLC sold out a holding in Epizyme Inc. The sale prices were between $13.68 and $20.46, with an estimated average price of $17.45.

Sold Out: Surface Oncology Inc (SURF)

NEA Management Company, LLC sold out a holding in Surface Oncology Inc. The sale prices were between $1.57 and $6.56, with an estimated average price of $3.58.

Sold Out: Lumos Pharma Inc (4NX1)

NEA Management Company, LLC sold out a holding in Lumos Pharma Inc. The sale prices were between $7.08 and $14.8, with an estimated average price of $10.5.

Sold Out: X4 Pharmaceuticals Inc (XFOR)

NEA Management Company, LLC sold out a holding in X4 Pharmaceuticals Inc. The sale prices were between $7.98 and $10.44, with an estimated average price of $9.15.



Here is the complete portfolio of NEA Management Company, LLC. Also check out:

1. NEA Management Company, LLC's Undervalued Stocks
2. NEA Management Company, LLC's Top Growth Companies, and
3. NEA Management Company, LLC's High Yield stocks
4. Stocks that NEA Management Company, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)